An Exploratory Study of ADR-001 in Patients with Severe Pneumonia Caused by SARS-CoV-2 Infection

NCT04522986 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Acute Respiratory Syndrome Coronavirus 2

Interventions

BIOLOGICAL: Mesenchymal stem cell

Sponsor

Rohto Pharmaceutical Co., Ltd.